Diagnostics

This category breaks down revolutionary technologies reimagining how the healthcare industry predicts, diagnoses, treats, and cures medical crises of today while making it accessible and affordable.

Zebra’s Artificial Intelligence Speeds Up Diagnosis for Patients

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Diagnostic-imaging company Zebra Medical Vision combines the knowledge of images and the power of the cloud to read X-Ray, CT and MRI scans faster...

OnSite Looks to Disrupt Medical-Waste Market By Staying On Site

OnSite Waste Technologies says the high costs and inefficiencies of medical waste disposal services makes the industry ripe for disruption. Just earlier this month, the Newport Beach, California-based OnSite closed a $3.5 million seed funding round, led by Mark IV Capital and...

Medication Drone Delivery Startup Zipline Attracts Major Investors

On Our Radar: Deals we are paying attention to, for their impact on industry. Zipline, a medicine drone-delivery startup, raised $190 million in funding from investors and donors including Goldman Sachs, signaling African’s daunting medical-care situation are attracting Silicon Valley and Wall Street’s attention. The California-based...

From Fertility to Fintech, Chiratae Ventures Tackles India’s Big Problems

Strategic Investors: Profiles of investors with strategies to consider. Chiratae Ventures has made a name for itself in India’s fast-growing venture capital scene with investments focused on innovative consumer tech, health and online retail. But the fund, part of the global IDG Ventures family, has...

Why Stuart Blitz thinks Elizabeth Holmes was “very correct about the trend of the market”

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Stuart Blitz has a dream. One day, someone will type ‘blood testing technology’ into Google and get the name of his company, Seventh Sense Bio, rather than Theranos. Seventh Sense Bio and...

Hatteras Venture Plans to Fund Life Science Startups With New Fund

On Our Radar: Deals we are paying attention to for their impact on industry. Venture capital firm Hatteras Venture Partners raised $94 million for its sixth fund, HVP VI, with plans to hit $200 million for investments in life science startups. Hatteras should reach its $200...

Sequoia and Highlight Give Cullgen $16M in Series A Financing

On Our Radar: Deals we are paying attention to for their impact on industry. Biotech firm Cullgen’s April 10 announcement that it had received a $16 million Series A financing aimed at advancing treatment of cancer and inflammatory and autoimmune diseases in a fresh way...

Sathya Elumalai: On the Cusp of Revolutionizing At-Home Care

Sound Businesses: Companies we are keeping an eye on. Sathya Elumalai is the CEO of Aidar Health, a digital healthcare company that provides monitoring of health data, cloud-based machine learning and other proprietary technology applications. Improving patient care globally has been the focus of my entire career. After...

Christian Bailey: “I realized there wasn’t someone connecting the solutions that were literally sitting on the shelf.”

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Skin cancer is the most commonly diagnosed cancer in America, with melanoma, the deadliest type, seeing a breakneck increase in diagnoses in the last 30 years, according to the American Cancer Society. But...

Charlie Kim: “Technologies are not looking at healthcare as a whole as a holistic system.”

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Hands up if, in 2016, you’d just bought new headphones to use with your iPhone, only to discover that Apple had ditched the 3.5 mm headphone jack for a Lightning connector....

Group K Diagnostics: “The most usable diagnostic will likely win out.”

Perspectives: Opinions from our network of advisors, investors, operators and analysts on the risks and opportunities they see. Just two drops of blood is all it takes — that is Sight Diagnostics’ promise to analyze, in a matter of seconds, any anomalies present. This point-of-care blood...
- Advertisement -